nodes	percent_of_prediction	percent_of_DWPC	metapath
Scopolamine—ABCB1—Vismodegib—skin cancer	0.155	0.557	CbGbCtD
Scopolamine—ABCB1—Dactinomycin—skin cancer	0.0812	0.292	CbGbCtD
Scopolamine—ABCB1—Docetaxel—skin cancer	0.0419	0.151	CbGbCtD
Scopolamine—Application site burn—Imiquimod—skin cancer	0.0393	0.063	CcSEcCtD
Scopolamine—CHRM3—muscle of abdomen—skin cancer	0.0257	0.259	CbGeAlD
Scopolamine—Rash generalised—Vemurafenib—skin cancer	0.0227	0.0364	CcSEcCtD
Scopolamine—Application site burn—Fluorouracil—skin cancer	0.0217	0.0348	CcSEcCtD
Scopolamine—Application site pain—Imiquimod—skin cancer	0.0187	0.03	CcSEcCtD
Scopolamine—CHRM5—skin epidermis—skin cancer	0.0168	0.169	CbGeAlD
Scopolamine—SI—female reproductive system—skin cancer	0.0105	0.106	CbGeAlD
Scopolamine—Skin irritation—Fluorouracil—skin cancer	0.0105	0.0169	CcSEcCtD
Scopolamine—Application site pain—Fluorouracil—skin cancer	0.0103	0.0166	CcSEcCtD
Scopolamine—SI—head—skin cancer	0.00879	0.0887	CbGeAlD
Scopolamine—Rash generalised—Docetaxel—skin cancer	0.00772	0.0124	CcSEcCtD
Scopolamine—Eczema—Imiquimod—skin cancer	0.00665	0.0107	CcSEcCtD
Scopolamine—Dry skin—Vemurafenib—skin cancer	0.00642	0.0103	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Vismodegib—skin cancer	0.00577	0.00926	CcSEcCtD
Scopolamine—Speech disorder—Temozolomide—skin cancer	0.00573	0.0092	CcSEcCtD
Scopolamine—Irritability—Imiquimod—skin cancer	0.0057	0.00915	CcSEcCtD
Scopolamine—Disturbance in attention—Temozolomide—skin cancer	0.00569	0.00913	CcSEcCtD
Scopolamine—Urinary retention—Imiquimod—skin cancer	0.00568	0.00911	CcSEcCtD
Scopolamine—Nervous system disorder—Vismodegib—skin cancer	0.00547	0.00877	CcSEcCtD
Scopolamine—CHRM5—epithelium—skin cancer	0.00546	0.0552	CbGeAlD
Scopolamine—Skin disorder—Vismodegib—skin cancer	0.00541	0.00868	CcSEcCtD
Scopolamine—Speech disorder—Fluorouracil—skin cancer	0.00528	0.00848	CcSEcCtD
Scopolamine—CHRM5—skin of body—skin cancer	0.0052	0.0525	CbGeAlD
Scopolamine—Redness—Docetaxel—skin cancer	0.00486	0.00779	CcSEcCtD
Scopolamine—Dysuria—Imiquimod—skin cancer	0.00483	0.00775	CcSEcCtD
Scopolamine—Fatigue—Vismodegib—skin cancer	0.00481	0.00771	CcSEcCtD
Scopolamine—Pain—Vismodegib—skin cancer	0.00477	0.00765	CcSEcCtD
Scopolamine—Constipation—Vismodegib—skin cancer	0.00477	0.00765	CcSEcCtD
Scopolamine—Depressed level of consciousness—Temozolomide—skin cancer	0.00476	0.00764	CcSEcCtD
Scopolamine—Disorientation—Bleomycin—skin cancer	0.00475	0.00761	CcSEcCtD
Scopolamine—Dry eye—Temozolomide—skin cancer	0.00456	0.00731	CcSEcCtD
Scopolamine—Eye disorder—Vemurafenib—skin cancer	0.00453	0.00727	CcSEcCtD
Scopolamine—Conjunctivitis—Imiquimod—skin cancer	0.00448	0.00718	CcSEcCtD
Scopolamine—Abdominal pain—Vismodegib—skin cancer	0.00441	0.00707	CcSEcCtD
Scopolamine—CHRM4—head—skin cancer	0.00434	0.0438	CbGeAlD
Scopolamine—Photophobia—Fluorouracil—skin cancer	0.00427	0.00685	CcSEcCtD
Scopolamine—Erythema—Vemurafenib—skin cancer	0.00422	0.00677	CcSEcCtD
Scopolamine—Pharyngitis—Imiquimod—skin cancer	0.0041	0.00658	CcSEcCtD
Scopolamine—Urinary tract disorder—Imiquimod—skin cancer	0.00408	0.00655	CcSEcCtD
Scopolamine—Urethral disorder—Imiquimod—skin cancer	0.00405	0.0065	CcSEcCtD
Scopolamine—Asthenia—Vismodegib—skin cancer	0.004	0.00642	CcSEcCtD
Scopolamine—Visual impairment—Imiquimod—skin cancer	0.00398	0.00639	CcSEcCtD
Scopolamine—Pruritus—Vismodegib—skin cancer	0.00394	0.00633	CcSEcCtD
Scopolamine—Eye disorder—Imiquimod—skin cancer	0.00386	0.0062	CcSEcCtD
Scopolamine—Flushing—Imiquimod—skin cancer	0.00384	0.00615	CcSEcCtD
Scopolamine—Amnesia—Temozolomide—skin cancer	0.00381	0.00611	CcSEcCtD
Scopolamine—Thirst—Temozolomide—skin cancer	0.00376	0.00604	CcSEcCtD
Scopolamine—Arrhythmia—Imiquimod—skin cancer	0.00369	0.00592	CcSEcCtD
Scopolamine—Disorientation—Fluorouracil—skin cancer	0.00369	0.00592	CcSEcCtD
Scopolamine—Mental disorder—Imiquimod—skin cancer	0.00362	0.00581	CcSEcCtD
Scopolamine—Erythema—Imiquimod—skin cancer	0.0036	0.00577	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.00357	0.00572	CcSEcCtD
Scopolamine—Vomiting—Vismodegib—skin cancer	0.00354	0.00568	CcSEcCtD
Scopolamine—Rash—Vismodegib—skin cancer	0.00351	0.00564	CcSEcCtD
Scopolamine—Amnesia—Fluorouracil—skin cancer	0.00351	0.00563	CcSEcCtD
Scopolamine—Dermatitis—Vismodegib—skin cancer	0.00351	0.00563	CcSEcCtD
Scopolamine—Dysphagia—Dactinomycin—skin cancer	0.00342	0.00549	CcSEcCtD
Scopolamine—CHRM5—head—skin cancer	0.00339	0.0343	CbGeAlD
Scopolamine—Nervous system disorder—Vemurafenib—skin cancer	0.00338	0.00542	CcSEcCtD
Scopolamine—Skin disorder—Vemurafenib—skin cancer	0.00334	0.00537	CcSEcCtD
Scopolamine—Nausea—Vismodegib—skin cancer	0.00331	0.00531	CcSEcCtD
Scopolamine—Agitation—Imiquimod—skin cancer	0.00331	0.0053	CcSEcCtD
Scopolamine—Dry skin—Temozolomide—skin cancer	0.00328	0.00526	CcSEcCtD
Scopolamine—Hypotension—Vemurafenib—skin cancer	0.00322	0.00516	CcSEcCtD
Scopolamine—Muscular weakness—Temozolomide—skin cancer	0.00316	0.00507	CcSEcCtD
Scopolamine—Irritability—Fluorouracil—skin cancer	0.00315	0.00505	CcSEcCtD
Scopolamine—Dysphagia—Temozolomide—skin cancer	0.00309	0.00496	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.00304	0.00488	CcSEcCtD
Scopolamine—Dry skin—Fluorouracil—skin cancer	0.00302	0.00485	CcSEcCtD
Scopolamine—Dry mouth—Imiquimod—skin cancer	0.003	0.00481	CcSEcCtD
Scopolamine—Fatigue—Vemurafenib—skin cancer	0.00297	0.00476	CcSEcCtD
Scopolamine—Constipation—Vemurafenib—skin cancer	0.00294	0.00472	CcSEcCtD
Scopolamine—Oedema—Imiquimod—skin cancer	0.00294	0.00471	CcSEcCtD
Scopolamine—Muscular weakness—Fluorouracil—skin cancer	0.00291	0.00467	CcSEcCtD
Scopolamine—Dysuria—Temozolomide—skin cancer	0.00289	0.00464	CcSEcCtD
Scopolamine—Nervous system disorder—Imiquimod—skin cancer	0.00288	0.00462	CcSEcCtD
Scopolamine—Tachycardia—Imiquimod—skin cancer	0.00287	0.0046	CcSEcCtD
Scopolamine—Skin disorder—Imiquimod—skin cancer	0.00285	0.00458	CcSEcCtD
Scopolamine—Dysphagia—Fluorouracil—skin cancer	0.00285	0.00457	CcSEcCtD
Scopolamine—Hyperhidrosis—Imiquimod—skin cancer	0.00284	0.00455	CcSEcCtD
Scopolamine—Flushing—Bleomycin—skin cancer	0.00273	0.00437	CcSEcCtD
Scopolamine—Body temperature increased—Vemurafenib—skin cancer	0.00272	0.00437	CcSEcCtD
Scopolamine—Pharyngitis—Dactinomycin—skin cancer	0.00272	0.00436	CcSEcCtD
Scopolamine—Somnolence—Imiquimod—skin cancer	0.00261	0.00419	CcSEcCtD
Scopolamine—Erythema—Bleomycin—skin cancer	0.00256	0.0041	CcSEcCtD
Scopolamine—Flushing—Dactinomycin—skin cancer	0.00254	0.00408	CcSEcCtD
Scopolamine—CHRM1—female reproductive system—skin cancer	0.00254	0.0256	CbGeAlD
Scopolamine—Fatigue—Imiquimod—skin cancer	0.00253	0.00406	CcSEcCtD
Scopolamine—Pain—Imiquimod—skin cancer	0.00251	0.00403	CcSEcCtD
Scopolamine—Conjunctivitis—Fluorouracil—skin cancer	0.00247	0.00396	CcSEcCtD
Scopolamine—Asthenia—Vemurafenib—skin cancer	0.00247	0.00396	CcSEcCtD
Scopolamine—Hallucination—Temozolomide—skin cancer	0.00246	0.00395	CcSEcCtD
Scopolamine—Pharyngitis—Temozolomide—skin cancer	0.00246	0.00394	CcSEcCtD
Scopolamine—Urinary tract disorder—Temozolomide—skin cancer	0.00245	0.00392	CcSEcCtD
Scopolamine—ABCB1—blood vessel—skin cancer	0.00244	0.0247	CbGeAlD
Scopolamine—Pruritus—Vemurafenib—skin cancer	0.00244	0.00391	CcSEcCtD
Scopolamine—Urethral disorder—Temozolomide—skin cancer	0.00243	0.0039	CcSEcCtD
Scopolamine—Feeling abnormal—Imiquimod—skin cancer	0.00242	0.00388	CcSEcCtD
Scopolamine—Visual impairment—Temozolomide—skin cancer	0.00239	0.00383	CcSEcCtD
Scopolamine—Erythema—Dactinomycin—skin cancer	0.00238	0.00382	CcSEcCtD
Scopolamine—CHRM2—head—skin cancer	0.00233	0.0235	CbGeAlD
Scopolamine—Body temperature increased—Imiquimod—skin cancer	0.00232	0.00372	CcSEcCtD
Scopolamine—Abdominal pain—Imiquimod—skin cancer	0.00232	0.00372	CcSEcCtD
Scopolamine—Eye disorder—Temozolomide—skin cancer	0.00231	0.00371	CcSEcCtD
Scopolamine—Flushing—Temozolomide—skin cancer	0.0023	0.00369	CcSEcCtD
Scopolamine—Dizziness—Vemurafenib—skin cancer	0.00228	0.00365	CcSEcCtD
Scopolamine—CHRM3—female reproductive system—skin cancer	0.00227	0.0229	CbGeAlD
Scopolamine—Pharyngitis—Fluorouracil—skin cancer	0.00227	0.00363	CcSEcCtD
Scopolamine—Vomiting—Vemurafenib—skin cancer	0.00219	0.00351	CcSEcCtD
Scopolamine—Dry skin—Docetaxel—skin cancer	0.00218	0.0035	CcSEcCtD
Scopolamine—Rash—Vemurafenib—skin cancer	0.00217	0.00348	CcSEcCtD
Scopolamine—Mental disorder—Temozolomide—skin cancer	0.00217	0.00348	CcSEcCtD
Scopolamine—Dermatitis—Vemurafenib—skin cancer	0.00217	0.00348	CcSEcCtD
Scopolamine—Headache—Vemurafenib—skin cancer	0.00216	0.00346	CcSEcCtD
Scopolamine—Erythema—Temozolomide—skin cancer	0.00216	0.00346	CcSEcCtD
Scopolamine—CHRM1—head—skin cancer	0.00212	0.0214	CbGeAlD
Scopolamine—Asthenia—Imiquimod—skin cancer	0.00211	0.00338	CcSEcCtD
Scopolamine—Confusional state—Bleomycin—skin cancer	0.0021	0.00337	CcSEcCtD
Scopolamine—Oedema—Bleomycin—skin cancer	0.00209	0.00335	CcSEcCtD
Scopolamine—Pruritus—Imiquimod—skin cancer	0.00208	0.00333	CcSEcCtD
Scopolamine—Dysphagia—Docetaxel—skin cancer	0.00206	0.0033	CcSEcCtD
Scopolamine—Nausea—Vemurafenib—skin cancer	0.00205	0.00328	CcSEcCtD
Scopolamine—Arrhythmia—Fluorouracil—skin cancer	0.00204	0.00327	CcSEcCtD
Scopolamine—Vision blurred—Temozolomide—skin cancer	0.00203	0.00326	CcSEcCtD
Scopolamine—Tremor—Temozolomide—skin cancer	0.00202	0.00324	CcSEcCtD
Scopolamine—Erythema—Fluorouracil—skin cancer	0.00199	0.00319	CcSEcCtD
Scopolamine—Agitation—Temozolomide—skin cancer	0.00198	0.00318	CcSEcCtD
Scopolamine—Hypotension—Bleomycin—skin cancer	0.00195	0.00313	CcSEcCtD
Scopolamine—Oedema—Dactinomycin—skin cancer	0.00195	0.00312	CcSEcCtD
Scopolamine—Dizziness—Imiquimod—skin cancer	0.00194	0.00312	CcSEcCtD
Scopolamine—Vertigo—Temozolomide—skin cancer	0.00194	0.00311	CcSEcCtD
Scopolamine—CHRM3—head—skin cancer	0.0019	0.0192	CbGeAlD
Scopolamine—Vision blurred—Fluorouracil—skin cancer	0.00187	0.003	CcSEcCtD
Scopolamine—Vomiting—Imiquimod—skin cancer	0.00187	0.003	CcSEcCtD
Scopolamine—Rash—Imiquimod—skin cancer	0.00185	0.00297	CcSEcCtD
Scopolamine—Dermatitis—Imiquimod—skin cancer	0.00185	0.00297	CcSEcCtD
Scopolamine—Headache—Imiquimod—skin cancer	0.00184	0.00295	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.00182	0.00292	CcSEcCtD
Scopolamine—Dry mouth—Temozolomide—skin cancer	0.0018	0.00288	CcSEcCtD
Scopolamine—Pain—Bleomycin—skin cancer	0.00178	0.00286	CcSEcCtD
Scopolamine—Conjunctivitis—Docetaxel—skin cancer	0.00178	0.00286	CcSEcCtD
Scopolamine—Confusional state—Temozolomide—skin cancer	0.00177	0.00285	CcSEcCtD
Scopolamine—Oedema—Temozolomide—skin cancer	0.00176	0.00282	CcSEcCtD
Scopolamine—Nausea—Imiquimod—skin cancer	0.00174	0.0028	CcSEcCtD
Scopolamine—Nervous system disorder—Temozolomide—skin cancer	0.00173	0.00277	CcSEcCtD
Scopolamine—Feeling abnormal—Bleomycin—skin cancer	0.00172	0.00276	CcSEcCtD
Scopolamine—Skin disorder—Temozolomide—skin cancer	0.00171	0.00274	CcSEcCtD
Scopolamine—Hyperhidrosis—Temozolomide—skin cancer	0.0017	0.00273	CcSEcCtD
Scopolamine—Fatigue—Dactinomycin—skin cancer	0.00168	0.00269	CcSEcCtD
Scopolamine—Pain—Dactinomycin—skin cancer	0.00166	0.00267	CcSEcCtD
Scopolamine—Body temperature increased—Bleomycin—skin cancer	0.00165	0.00265	CcSEcCtD
Scopolamine—Confusional state—Fluorouracil—skin cancer	0.00163	0.00262	CcSEcCtD
Scopolamine—Pharyngitis—Docetaxel—skin cancer	0.00163	0.00262	CcSEcCtD
Scopolamine—Urinary tract disorder—Docetaxel—skin cancer	0.00163	0.00261	CcSEcCtD
Scopolamine—Oedema—Fluorouracil—skin cancer	0.00162	0.0026	CcSEcCtD
Scopolamine—Urethral disorder—Docetaxel—skin cancer	0.00161	0.00259	CcSEcCtD
Scopolamine—Feeling abnormal—Dactinomycin—skin cancer	0.0016	0.00257	CcSEcCtD
Scopolamine—Nervous system disorder—Fluorouracil—skin cancer	0.00159	0.00255	CcSEcCtD
Scopolamine—Visual impairment—Docetaxel—skin cancer	0.00159	0.00255	CcSEcCtD
Scopolamine—Tachycardia—Fluorouracil—skin cancer	0.00158	0.00254	CcSEcCtD
Scopolamine—Somnolence—Temozolomide—skin cancer	0.00156	0.00251	CcSEcCtD
Scopolamine—Eye disorder—Docetaxel—skin cancer	0.00154	0.00247	CcSEcCtD
Scopolamine—Abdominal pain—Dactinomycin—skin cancer	0.00154	0.00247	CcSEcCtD
Scopolamine—Body temperature increased—Dactinomycin—skin cancer	0.00154	0.00247	CcSEcCtD
Scopolamine—Flushing—Docetaxel—skin cancer	0.00153	0.00245	CcSEcCtD
Scopolamine—Fatigue—Temozolomide—skin cancer	0.00152	0.00243	CcSEcCtD
Scopolamine—Hypotension—Fluorouracil—skin cancer	0.00152	0.00243	CcSEcCtD
Scopolamine—Constipation—Temozolomide—skin cancer	0.0015	0.00241	CcSEcCtD
Scopolamine—Pain—Temozolomide—skin cancer	0.0015	0.00241	CcSEcCtD
Scopolamine—Asthenia—Bleomycin—skin cancer	0.0015	0.0024	CcSEcCtD
Scopolamine—Pruritus—Bleomycin—skin cancer	0.00148	0.00237	CcSEcCtD
Scopolamine—Arrhythmia—Docetaxel—skin cancer	0.00147	0.00236	CcSEcCtD
Scopolamine—Feeling abnormal—Temozolomide—skin cancer	0.00145	0.00233	CcSEcCtD
Scopolamine—Mental disorder—Docetaxel—skin cancer	0.00144	0.00232	CcSEcCtD
Scopolamine—Somnolence—Fluorouracil—skin cancer	0.00144	0.00231	CcSEcCtD
Scopolamine—Erythema—Docetaxel—skin cancer	0.00143	0.0023	CcSEcCtD
Scopolamine—Asthenia—Dactinomycin—skin cancer	0.0014	0.00224	CcSEcCtD
Scopolamine—Body temperature increased—Temozolomide—skin cancer	0.00139	0.00223	CcSEcCtD
Scopolamine—Abdominal pain—Temozolomide—skin cancer	0.00139	0.00223	CcSEcCtD
Scopolamine—Pain—Fluorouracil—skin cancer	0.00139	0.00222	CcSEcCtD
Scopolamine—Feeling abnormal—Fluorouracil—skin cancer	0.00134	0.00214	CcSEcCtD
Scopolamine—Vomiting—Bleomycin—skin cancer	0.00133	0.00213	CcSEcCtD
Scopolamine—Rash—Bleomycin—skin cancer	0.00132	0.00211	CcSEcCtD
Scopolamine—Dermatitis—Bleomycin—skin cancer	0.00131	0.00211	CcSEcCtD
Scopolamine—Body temperature increased—Fluorouracil—skin cancer	0.00128	0.00206	CcSEcCtD
Scopolamine—Asthenia—Temozolomide—skin cancer	0.00126	0.00203	CcSEcCtD
Scopolamine—Pruritus—Temozolomide—skin cancer	0.00125	0.002	CcSEcCtD
Scopolamine—Nausea—Bleomycin—skin cancer	0.00124	0.00199	CcSEcCtD
Scopolamine—Vomiting—Dactinomycin—skin cancer	0.00124	0.00198	CcSEcCtD
Scopolamine—Rash—Dactinomycin—skin cancer	0.00123	0.00197	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.00121	0.00194	CcSEcCtD
Scopolamine—Dry mouth—Docetaxel—skin cancer	0.00119	0.00192	CcSEcCtD
Scopolamine—ABCB1—epithelium—skin cancer	0.00119	0.012	CbGeAlD
Scopolamine—Confusional state—Docetaxel—skin cancer	0.00118	0.00189	CcSEcCtD
Scopolamine—Oedema—Docetaxel—skin cancer	0.00117	0.00188	CcSEcCtD
Scopolamine—Dizziness—Temozolomide—skin cancer	0.00116	0.00187	CcSEcCtD
Scopolamine—Nausea—Dactinomycin—skin cancer	0.00116	0.00185	CcSEcCtD
Scopolamine—Nervous system disorder—Docetaxel—skin cancer	0.00115	0.00184	CcSEcCtD
Scopolamine—Pruritus—Fluorouracil—skin cancer	0.00115	0.00184	CcSEcCtD
Scopolamine—Tachycardia—Docetaxel—skin cancer	0.00114	0.00183	CcSEcCtD
Scopolamine—Skin disorder—Docetaxel—skin cancer	0.00114	0.00182	CcSEcCtD
Scopolamine—Vomiting—Temozolomide—skin cancer	0.00112	0.00179	CcSEcCtD
Scopolamine—Rash—Temozolomide—skin cancer	0.00111	0.00178	CcSEcCtD
Scopolamine—Dermatitis—Temozolomide—skin cancer	0.00111	0.00178	CcSEcCtD
Scopolamine—Headache—Temozolomide—skin cancer	0.0011	0.00177	CcSEcCtD
Scopolamine—Hypotension—Docetaxel—skin cancer	0.00109	0.00175	CcSEcCtD
Scopolamine—Dizziness—Fluorouracil—skin cancer	0.00107	0.00172	CcSEcCtD
Scopolamine—Nausea—Temozolomide—skin cancer	0.00105	0.00168	CcSEcCtD
Scopolamine—Somnolence—Docetaxel—skin cancer	0.00104	0.00167	CcSEcCtD
Scopolamine—Vomiting—Fluorouracil—skin cancer	0.00103	0.00165	CcSEcCtD
Scopolamine—ABCB1—mammalian vulva—skin cancer	0.00103	0.0104	CbGeAlD
Scopolamine—Rash—Fluorouracil—skin cancer	0.00102	0.00164	CcSEcCtD
Scopolamine—Dermatitis—Fluorouracil—skin cancer	0.00102	0.00164	CcSEcCtD
Scopolamine—Headache—Fluorouracil—skin cancer	0.00102	0.00163	CcSEcCtD
Scopolamine—Fatigue—Docetaxel—skin cancer	0.00101	0.00162	CcSEcCtD
Scopolamine—Pain—Docetaxel—skin cancer	0.001	0.00161	CcSEcCtD
Scopolamine—Constipation—Docetaxel—skin cancer	0.001	0.00161	CcSEcCtD
Scopolamine—Feeling abnormal—Docetaxel—skin cancer	0.000964	0.00155	CcSEcCtD
Scopolamine—Nausea—Fluorouracil—skin cancer	0.000963	0.00155	CcSEcCtD
Scopolamine—Body temperature increased—Docetaxel—skin cancer	0.000925	0.00148	CcSEcCtD
Scopolamine—Abdominal pain—Docetaxel—skin cancer	0.000925	0.00148	CcSEcCtD
Scopolamine—ABCB1—lymphoid tissue—skin cancer	0.000915	0.00924	CbGeAlD
Scopolamine—ABCB1—female reproductive system—skin cancer	0.000883	0.00892	CbGeAlD
Scopolamine—Asthenia—Docetaxel—skin cancer	0.00084	0.00135	CcSEcCtD
Scopolamine—Pruritus—Docetaxel—skin cancer	0.000828	0.00133	CcSEcCtD
Scopolamine—Dizziness—Docetaxel—skin cancer	0.000774	0.00124	CcSEcCtD
Scopolamine—Vomiting—Docetaxel—skin cancer	0.000744	0.00119	CcSEcCtD
Scopolamine—Rash—Docetaxel—skin cancer	0.000738	0.00118	CcSEcCtD
Scopolamine—ABCB1—head—skin cancer	0.000738	0.00745	CbGeAlD
Scopolamine—Dermatitis—Docetaxel—skin cancer	0.000737	0.00118	CcSEcCtD
Scopolamine—Headache—Docetaxel—skin cancer	0.000733	0.00118	CcSEcCtD
Scopolamine—Nausea—Docetaxel—skin cancer	0.000695	0.00112	CcSEcCtD
Scopolamine—ABCB1—lymph node—skin cancer	0.000516	0.00522	CbGeAlD
